triazolam has been researched along with Hypesthesia in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this prospective, randomized, double-blind, placebo-controlled study was to determine the effect of the administration of sublingual triazolam on the success of the inferior alveolar nerve (IAN) block in patients experiencing irreversible pulpitis." | 9.13 | Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis. ( Beck, M; Drum, M; Lindemann, M; Nusstein, J; Reader, A, 2008) |
| "The purpose of this prospective, randomized, double-blind, placebo-controlled study was to determine the effect of the administration of sublingual triazolam on the success of the inferior alveolar nerve (IAN) block in patients experiencing irreversible pulpitis." | 5.13 | Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis. ( Beck, M; Drum, M; Lindemann, M; Nusstein, J; Reader, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindemann, M | 1 |
| Reader, A | 1 |
| Nusstein, J | 1 |
| Drum, M | 1 |
| Beck, M | 1 |
| Ohshima, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Preoperative Alprazolam on the Success of Inferior Alveolar Nerve Block for Teeth With Irreversible Pulpitis[NCT01546090] | Phase 4 | 60 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for triazolam and Hypesthesia
| Article | Year |
|---|---|
Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis.
Topics: Adjuvants, Anesthesia; Administration, Sublingual; Adolescent; Adult; Anesthesia, Dental; Anti-Anxie | 2008 |
1 other study available for triazolam and Hypesthesia
| Article | Year |
|---|---|
Criminal injury case using vegetable juice intermixed with triazolam.
Topics: Amnesia, Anterograde; Beverages; Crime; Dose-Response Relationship, Drug; Fatigue; Female; Forensic | 2005 |